PN
Pavuttakunnan Noufal
About Pavuttakunnan Noufal
Data last updated:
Pavuttakunnan Noufal is a Managing Director at Cims Healthcare Private Limited (since 2019) and Designated Partner at Cims Pharmaceuticals Llp (since 2017). The companies operate in Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cims Healthcare Private Limited U24110KA2019PTC128692 | Managing Director | 14 Oct 2019 | 2019 | Active | |
 Cims Pharmaceuticals Llp AAL-5451 | Designated Partner | 28 Dec 2017 | 2017 | Active |
Board colleagues of Pavuttakunnan Noufal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jamsheela Kurikkal | 09148074 | Cims Healthcare Private Limited , Cims Pharmaceuticals Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pavuttakunnan Noufal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pavuttakunnan Noufal
Pavuttakunnan Noufal currently holds 2 directorships: Cims Healthcare Private Limited (Managing Director, since 14 Oct 2019); Cims Pharmaceuticals Llp (Designated Partner, since 28 Dec 2017).
Pavuttakunnan Noufal was first appointed on 28 Dec 2017 as Designated Partner at Cims Pharmaceuticals Llp. The most recent appointment on record is 14 Oct 2019 at Cims Healthcare Private Limited.
The current boards of Pavuttakunnan Noufal's companies include Jamsheela Kurikkal (Cims Healthcare Private Limited).